Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
about
Dopamine agonists for the treatment of cocaine dependenceDopamine agonists for the treatment of cocaine dependenceAntidepressants for cocaine dependence and problematic cocaine useAstrocytic dysfunction and addiction: consequences of impaired glutamate homeostasisGlial modulators: a novel pharmacological approach to altering the behavioral effects of abused substancesSerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderNew treatments for cocaine dependence: a focused reviewDopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humansNew developments in the pharmacotherapy of cocaine abuseWhy do some promising brain-stimulation devices fail the next steps of clinical development?Riluzole in psychiatry: a systematic review of the literature.Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate HomeostasisControversies in translational research: drug self-administration.Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism.Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug AbuseGlial and neuroinflammatory targets for treating substance use disorders.Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals.Riluzole Impairs Cocaine Reinstatement and Restores Adaptations in Intrinsic Excitability and GLT-1 Expression.Reversing Cocaine-Induced Adaptations and Reducing Relapse: An Opportunity for Repurposing Riluzole.
P2860
Q24187799-FE9F00B1-8F80-4753-9E1E-04D68145293BQ24234240-01B87EBF-C3DE-4007-8CED-EF4BDF363BAAQ24234248-AF98502C-0C3B-4E79-B766-8D3D7CF428F8Q26996339-2E9841F4-CB91-42ED-8F95-966808F50A58Q27003932-6CDD01F8-D735-4283-8C22-9C74F8DEE633Q27015917-68065AD3-5EBB-4B0D-B601-49F4E2B8C890Q28252765-45AF84A7-DD38-4DE6-98D1-3514D139FCDCQ28265851-F37E7A7A-8548-4CD0-BE95-D57F1E7E5808Q28302782-1740D6E4-3588-46F3-9B6A-B4D0F4CF5830Q33519672-5AFD750C-8597-4C26-8F81-EC6BF804F2B3Q36983354-E638EAF9-2370-45EE-BE2F-0D49CF340FC0Q37062538-4FD51B9B-B0FF-43A4-A246-4CC515662E59Q37062547-73CBF8E2-2463-4EB7-86D6-6BB857AEC9E1Q37087986-8F139A5A-3241-4604-A880-D308748192D7Q37409585-4AF91958-DBD3-4DB4-971D-8DD808D5CE5FQ38729846-3D676A04-4AA7-4A15-9067-2EC821C123B9Q43076075-12849E8D-1B54-4F78-8238-A589D28C73A8Q47574610-B3B32108-44FB-499D-9E08-3EC6192D1942Q48027976-B6B45FC5-B85F-41AF-BEF8-42645CBB765BQ48231657-8E7CAA2E-0FF1-457C-9369-3CA434262B38
P2860
Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Efficacy screening trials of p ...... afaxine in cocaine dependence.
@en
Efficacy screening trials of p ...... afaxine in cocaine dependence.
@nl
type
label
Efficacy screening trials of p ...... afaxine in cocaine dependence.
@en
Efficacy screening trials of p ...... afaxine in cocaine dependence.
@nl
prefLabel
Efficacy screening trials of p ...... afaxine in cocaine dependence.
@en
Efficacy screening trials of p ...... afaxine in cocaine dependence.
@nl
P2093
P50
P1433
P1476
Efficacy screening trials of p ...... afaxine in cocaine dependence.
@en
P2093
Ahmed Elkashef
Daniel A Bloch
Deborah B Leiderman
Joseph LoCastro
Margaret A Montgomery
P356
10.1111/J.1360-0443.2005.00985.X
P407
P478
100 Suppl 1
P577
2005-03-01T00:00:00Z